FDA can approve after 12 years of data exclusivity for the manufacturing of a new biologic agent. This describes which concept?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the BCPS Regulatory Test. Prepare with flashcards and multiple choice questions, each question includes hints and explanations to get you ready for the exam!

Multiple Choice

FDA can approve after 12 years of data exclusivity for the manufacturing of a new biologic agent. This describes which concept?

Explanation:
Regulatory exclusivity. This is time-based protection granted by the FDA that blocks approval of a competing product using the sponsor’s data for a defined period. For new biologics, the Biologics Price Competition and Innovation Act provides 12 years of data exclusivity, meaning a biosimilar cannot rely on the reference product’s safety and efficacy data to gain approval during those 12 years. After that window, the data can be used to support approval (if all other requirements are met). This concept is separate from patent protection, which is a different form of exclusivity.

Regulatory exclusivity. This is time-based protection granted by the FDA that blocks approval of a competing product using the sponsor’s data for a defined period. For new biologics, the Biologics Price Competition and Innovation Act provides 12 years of data exclusivity, meaning a biosimilar cannot rely on the reference product’s safety and efficacy data to gain approval during those 12 years. After that window, the data can be used to support approval (if all other requirements are met). This concept is separate from patent protection, which is a different form of exclusivity.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy